Sentence examples for development procedure to from inspiring English sources
A complete model development procedure to investigate all available covariate effects was not performed in the current analysis because this had been conducted in previously reported work.
Therefore, the aim of this study is to develop and test a tailored strategy to implement both the NVOG guideline and MOET-instructions One step in the development procedure is to evaluate the implementation of the guideline and MOET-instructions in the current care.
Two other characteristics of randomised controlled trials were added as correct answers for this item as a result of answers provided by students during the survey development procedure (refer to the K-REC marking guidelines in Additional file 2).
As the result, the study suggests the use of dynamic assessment as a development-oriented procedure to diagnose and develop the learnersˊ emerging abilities.
The development procedure is identical to that in Figure 5.
The instrument development procedure was designed to ensure good content validity, and the assessment indicated that the questionnaire has good reliability.
On implication side, the paper recommends the use of DA as a development-oriented procedure to assess the learners' abilities, a procedure which focuses on the learners' emerging abilities in constantly innovative tasks.
The questionnaire development procedure was a kin to works by Thrusfield (1986) and Osotimehin et al. (2006) and included open and closed-ended types of questions.
Since the AMG development procedure is very sensitive to temperature and other parameters, the brain sections from sham control, vehicle-treated and CQ-treated ischemic gerbils were incubated in the AMG developer in the same jar at the same time.
Overall, the initial clinical validation step in our biomarker development procedure has allowed us to answer two critical questions for the potential applicability of the biomarker in clinical practice; hence, in our opinion, this step is essential for fast streamlining of the biomarker validation process.
The evaluation of potential adverse effects of pharmaceuticals on the immune system is part of the standard drug development procedures and needs to be available prior to the start of phase III clinical trials.
